SEC Filings

AVEXIS, INC. filed this Form S-1/A on 02/09/2016
Entire Document

Table of Contents

The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

Subject to Completion. Dated February 9, 2016



Common Stock

           This is an initial public offering of shares of common stock of AveXis, Inc. All of the 4,250,000 shares of our common stock are being sold by the company.

           Prior to this offering, there has been no public market for our common stock. It is currently estimated that the initial public offering price per share will be between $19.00 and $21.00. We have applied to list our common stock on The NASDAQ Global Select Market under the symbol "AVXS."

           We are an "emerging growth company" as that term is used in the Jumpstart Our Business Startups Act of 2012 and, as such, have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings.

           See "Risk Factors" on page 11 to read about factors you should consider before buying shares of our common stock.

           Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.

Per Share

Initial public offering price

  $     $    

Underwriting discounts and commissions(1)

  $     $    

Proceeds to AveXis, Inc., before expenses

  $     $    

See "Underwriting" beginning on page 191 for additional information regarding underwriting compensation.

           Certain of our significant stockholders have indicated an interest in purchasing up to an aggregate of $30 million in shares of our common stock in this offering at the initial public offering price per share. However, because indications of interest are not binding agreements or commitments to purchase, the underwriters may determine to sell more, less or no shares in this offering to any of these entities, or any of these entities may determine to purchase more, less or no shares in this offering. The underwriters will receive the same underwriting discount on any shares purchased by these entities as they will on any other shares sold to the public in this offering.

           To the extent that the underwriters sell more than 4,250,000 shares of common stock, the underwriters have the option to purchase up to an additional 637,500 shares from us at the initial price to the public less the underwriting discount, within 30 days from the date of this prospectus.

           The underwriters expect to deliver the shares against payment in New York, New York on or about                  , 2016.

Goldman, Sachs & Co.   Jefferies
BMO Capital Markets


Prospectus dated         , 2016

© AveXis, Inc. All Rights Reserved.